Technology Updates

As part of a new series of updates on technology, and to complement on Clinuvel's public news flow, Clinuvel has initiated a regular bulletin to provide its followers worldwide with the latest advances on relevant issues, such as environmental factors, skin and related biochemical issues.

These discussions aim to increase the understanding of the science and technology behind Clinuvel’s progress in pharmaceutical development. Where the depth of information becomes too profound we have tried to summarise concepts into easier terms.

Technology Update I - The physiological "UV tanning response", original thoughts on UV and pigmentation

Technology Update II - Afamelanotide as an adjunct to phototherapy

Technology Update III - Stem cells and repigmentation in vitiligo

SCENESSE® Blog Posts

In what has become something of a tradition in recent years, yet another country has used the new year to adopt further laws related to...

Read More

Allergan’s lawsuit filed against the FDA presents a relatively novel case in addressing the requirements of drug developers in relation...

Read More

Following on from last week’s conversation, I left off with the issues surrounding the off-label prescriptive habits by physicians and...

Read More

SCENESSE® Webcasts

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now